Evaluation of the efficacy of octreotide LAR in the treatment of Crohn's disease associated refractory diarrhea.

peer reviewed ; OBJECTIVES: Diarrhea is one of the main symptoms of Crohn's disease (CD). It is usually significantly improved with specific CD treatments, loperamide or cholestyramine. However, in some cases, diarrhea becomes refractory. The aim of this study was to assess the safety and efficacy of octreotide in this situation. MATERIALS AND METHODS: Fifteen patients with CD refractory diarrhea defined by at least an average of five smooth or liquid stools per day despite an optimized CD treatment were included from three Belgian centers. Two patients were lost to follow-up. A subcutaneous i... Mehr ...

Verfasser: Martelli, Laura
Colard, Arnaud
Fontaine, Fernand
Deflandre, Jacques
Bastens, Boris
Louis, Edouard
Dokumenttyp: journal article
Erscheinungsdatum: 2017
Verlag/Hrsg.: Taylor & Francis
Schlagwörter: Adult / Belgium / Crohn Disease/drug therapy / Diarrhea/drug therapy / Feces / Female / Gastrointestinal Agents/administration & dosage / Humans / Injections / Subcutaneous / Male / Middle Aged / Octreotide/administration & dosage / Treatment Outcome / Crohn's disease / Sandostatin(R) LAR / octreotide / open-label study / refractory diarrhea / Human health sciences / Gastroenterology & hepatology / Sciences de la santé humaine / Gastroentérologie & hépatologie
Sprache: Englisch
Permalink: https://search.fid-benelux.de/Record/base-26976848
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : https://orbi.uliege.be/handle/2268/221493